Most clinical studies settle for the part of drugs modulating via NMDA receptors. Ketamine is noncompetitive voltage-dependent NMDA-receptor channel blocker whose antidepressant action is obvious at lower doses, and with growing doses, it mimics psychotomimetic action and eventually brings about anesthesia in bigger doses.[4]By the time he was fort